bromopyruvate

glyceraldehyde-3-phosphate dehydrogenase ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30395437 Bioorthogonal Profiling of a Cancer Cell Proteome Identifies a Large Set of 3-Bromopyruvate Targets beyond Glycolysis. 2018 Nov 16 2
2 28387379 Relationship between Porcine Sperm Motility and Sperm Enzymatic Activity using Paper-based Devices. 2017 Apr 7 4
3 25644152 Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro. 2015 Apr 1
4 24715475 Transport of 3-bromopyruvate across the human erythrocyte membrane. 2014 Jun 2
5 23267123 Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. 2013 Jan 2
6 22357877 Science to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists? 2012 Mar 2
7 22357885 Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists. 2012 Mar 7
8 20393016 3-Bromopyruvate induces endoplasmic reticulum stress, overcomes autophagy and causes apoptosis in human HCC cell lines. 2010 Mar 2
9 20420565 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy. 2010 Aug 1
10 20044597 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. 2009 Dec 9